Surgical treatment of gastric gastrointestinal stromal tumors: Analysis of 92 operated patients

Digestive Surgery

Volumn 25, Issue 3, 2008, Pages 208-212

  Lai, I Rue ^a   Chen, Chiung Nien ^a   Lin, Ming Tsan ^a   Lee, Po Huang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Gastrointestinal stromal tumor (GIST); Recurrence, GIST; Stomach, GIST

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; INDEPENDENT VARIABLE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LIVER NEOPLASMS; MALE; MESENCHYMOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMACH NEOPLASMS;

EID: 49449118028     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140691     Document Type: Article

References (26)

1. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580.
2. Rubin BP, Fletcher JA, Fletcher CDM: Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors. Int J Surg Pathol 2000;8:5-10.
3. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-1269.
4. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213-1230.
5. Tagaya N, Mikami H, Kubota K: Laparoscopic resection of gastrointestinal mesenchymal tumors located in the upper stomach. Surg Endosc 2004;18:1469-1474
6. Emory TS, Sobin LH, Lukes L, et al: Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999;23:82-87.
7. Strickland L, Letson GD, Muro-Cacho CA: Gastrointestinal stromal tumors. Cancer Control 2001;8:252-261.
8. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T: Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39-48.
9. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, et al: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-465.
10. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC: KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002;160:1567-1572.
11. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH: Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377-389.
12. Miettinen M, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68.
13. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480.
14. Ng EH, Pollock RE, Romsdahl MM: Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69:1334-1341.
15. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.
16. Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, Kubota T, Mukai M, Kameyama K, Sugino Y, Kumai K, Kitajima M: Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery 2006;139:484-492.
17. Langer C, Gunawan B, Schüler P, Huber W, Füzesi L, Becker H: Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumors. Br J Surg 2003;90:332-339.
18. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF: Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001;234:540-547.
19. Lai IR, Hu RH, Chang KJ: Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors. Hepatogastroenterology 2005;52:826-828.
20. Zhan WH, Wang PZ, Shao YF, et al: Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi 2006;9:383-387.
21. Gold JS, Dematteo RP: Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 2006;244:176-184.
22. Matthews BD, Walsh RM, Kercher KW, et al: Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc 2002;16:803-807.
23. Yoshida M, Otani Y, Ohgami M, et al: Surgical management of gastric leiomyosarcoma: evaluation of the propriety of laparoscopic wedge resection. World J Surg 1997;21:440-443.
24. Heinrich MC, Corless CL: Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol 2005;90:195-207.
25. Yasui H, Konishi E, Urasaki K, Yasukawa S, Yanagisawa A: Intratumoral heterogeneity of MIB-1 labelling index in gastric gastrointestinal stromal tumor (GIST). Gastric Cancer 2006;9:223-228.
26. Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan YY, Chen MF: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol 2006;6:29-36.